~~<i id='E7DB0C7EA1'><strike id='E7DB0C7EA1'><tt id='E7DB0C7EA1'><pre id='E7DB0C7EA1'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

leisure time

focus

author：leisure time 2025-08-21 06:56:06 - browse：19698

A tumor invasion into vein in a case of colorectal cancer -- cancer coverage from STAT — A tumor invasion into a vein in a case of colorectal cancer. Wikimedia Commons

When both the nurse and the doctor broke down in tears as they delivered the news, Chris Gosline knew that something difficult lay ahead.

It was 5 a.m., after a long night in the emergency department at Beverly Hospital, where he’d gone for help with severe pain in his shoulder. A scan had detected tumors on his liver. Turns out, there’s a nerve connection that makes shoulder pain a possible sign of liver disease.

Further testing over the next couple of weeks clarified the cause: Gosline had stage 4 colorectal cancer, which had spread to his liver.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Hollywood unions extend contract negotiations for actors
Next article： R1 RCM gets $5.8 billion buyout offer from private equity firm

leisure time

explore

focus

leisure time

focus

Hevolution'sexecutiveteamincludes,fromleft,SophiaPathai,HayaBintKhaledBinBandarAlSaud,MehmoodKhan,an

WSS

Fetal surgery at risk from Dobbs and new abortion restrictions

With clinical trial data readouts, here's how to spot spin

Readout Newsletter: The latest in Pfizer, Moderna, and Sanofi

FDA investigates CAR

What to do when lifesaving products contribute to climate change

What don’t we know about an Alzheimer’s drug side effect?

leisure time

focus

leisure time

Cancer drug shortages should be causing more outrage

J&J to emphasize cancer drugs, stop much of its vaccine research

Peter Hotez and the public health issue of online harassment

ReNAgade cuts staff seven months after raising $300 million

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

The EPA's new lead rule: How one expert crunched the numbers

How to save PrEP access — and even expand it

A solution to the after

Bright Health sells Medicare Advantage business to Molina

Pediatric cancer treatments threatened by a new FDA policy

explore

Readout LOUD podcast: Humira legacy, AbbVie CEO's retirement

He's a Nobel laureate. Critics say he was misleading on Covid

Is mRNA technology the right fit for flu shots? Experts aren’t so sure

In utero gene editing: an explainer

Is mRNA technology the right fit for flu shots? Experts aren’t so sure

Mayo Clinic plans $5B tech

explore

focus

leisure time

focus